SAR and identification of 2-(quinolin-4-yloxy)acetamides as Mycobacterium tuberculosis cytochrome bc (1) inhibitors

A previous phenotypic screen by GSK identified 2-(quinolin-4-yloxy)acetamides as potent growth inhibitors of Mycobacterium tuberculosis (Mtb). We report the results of a preliminary structure–activity relationship (SAR) study of the compound class which has yielded more potent inhibitors. An Mtb cyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Phummarin, Narisa, Boshoff, Helena I., Tsang, Patricia S., Dalton, James, Wiles, Siouxsie, Barry 3rd, Clifton E., Copp, Brent R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal Society of Chemistry 2016
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292992/
https://www.ncbi.nlm.nih.gov/pubmed/28337336
http://dx.doi.org/10.1039/c6md00236f

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292992/
https://www.ncbi.nlm.nih.gov/pubmed/28337336
http://dx.doi.org/10.1039/c6md00236f

Ejemplares similares